LSU researcher receives $1.8 million NIH grant to study proteins in rickettsial species

February 20, 2015

Juan J. Martinez, PhD, associate professor in the Department of Pathobiological Sciences at the LSU School of Veterinary Medicine, has been awarded a 5-year grant from the National Institutes of Health, National Institute of Allergy and Infectious Disease. This award is a renewal of an existing NIH R01 grant in the amount of $1,832,000, for the calendar years 2015-2020. Dr. Martinez' research group seeks to further understand the contribution of a family of outer-membrane proteins termed surface cell antigens, expressed by pathogenic rickettsial species to the initiation and progression of disease in animals and humans.

Dr. Martinez and his team are studying Rickettsia rickettsii, Rickettsia conorii, Rocky Mountain Spotted Fever (RMSF) and Mediterranean spotted fever (MSF). The goal is to identify proteins that play a role in pathogenesis and then to develop strategies to inhibit their function.

"Most of the studies that we do rely on identifying the function of an outer-membrane protein and investigating whether immunization of an animal (mouse) with this protein elicits protective immune responses against fatal disease," said Dr. Martinez.

The members of the research team are as follows:

Juan Martinez, PhD, principal investigator. Dr. Martinez will retain the personnel with state-of-the-art techniques and oversee the overall project. Dr. Martinez is an expert in techniques that will be used in this project and has extensive experience in rickettsial research.

Sean P. Riley, PhD, assistant professor-research. Dr. Riley will be actively involved in further developing the animal model of disseminated, fatal disease. In particular, he will be responsible for the characterization of the generated mutants in in vitro and in vivo models of rickettsial infections. He will also be involved in the generation of polyclonal antibodies against rickettsial proteins of interest and then will further test the efficacy of these reagents to generate protective immunity against fatal RMSF.

Fabio DelPiero, DVM, PhD, DACVP, professor and co-investigator. Dr. DelPiero will be responsible primarily for the histopathologic analysis and scoring of isolated tissues and organs from the murine model of disseminated rickettsial disease. Dr. Del Piero is a board certified anatomical pathologist and a diplomate of the American College of Veterinary Pathologists and has extensive experience determining pathologic injuries in murine models of infectious diseases.

Daniel Garza, research technologist. Garza will the support of construction and isolation of mutants in rickettsial genes of interest and to initially characterize them using an in vitro model of rickettsia-host cell interactions (Aim 2). He will also have a strong background in bio-informatic analysis of large data sets and will be responsible for the data mining and analysis of transcriptome sequencing (RNA-seq) results.

Elizabeth Griggs, graduate student. She will participate in the studies regarding the construction and characterization of mutants outlined in (Aim1 and Aim2) using in vivo models of infections. Griggs is versed in animal handling and will be involved in understanding the contribution of generating protective immune responses by active vaccination.

"This renewal will bolster our efforts to elucidate the function of this family of conserved proteins present in pathogenic rickettsial species and to potentially exploit them for the development of targeted and efficacious anti-rickettsial therapies," said Dr. Martinez. "I would like to thank my talented research team and collaborators here at the LSU SVM, without whom this would not have been possible."
-end-


Louisiana State University

Related Infectious Disease Articles from Brightsurf:

Archaeology uncovers infectious disease spread - 4000 years ago
New bioarchaeology research from a University of Otago PhD candidate has shown how infectious diseases may have spread 4000 years ago, while highlighting the dangers of letting such diseases run rife.

Lack of continuous infectious disease pandemic research endangers responses
The coronavirus was also studied considerably less than blood borne viruses like Hepatitis B or C and H.I.V. and its research community has less prolific researchers than the other investigated diseases.

For patients with sepsis, an infectious disease expert may reduce the risk of death
When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room (ER), they require timely, expert care to prevent organ failure and even death.

Infectious disease in marine life linked to decades of ocean warming
New research shows that long-term changes in diseases in ocean species coincides with decades of widespread environmental change.

What makes some people more receptive to the idea of being vaccinated against infectious disease?
Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study in the journal Heliyon, published by Elsevier.

Can we feed 11 billion people while preventing the spread of infectious disease?
A new article published in Nature Sustainability describes how the increase in population and the need to feed everyone will give rise to human infectious disease, a situation the authors of the paper consider 'two of the most formidable ecological and public health challenges of the 21st century.'

Climate change responsible for severe infectious disease in UK frogs
Climate change has already increased the spread and severity of a fatal disease caused by Ranavirus that infects common frogs (Rana temporaria) in the UK, according to research led by ZSL's Institute of Zoology, UCL and Queen Mary University of London published today in Global Change Biology.

New research framework may help better understand, predict infectious disease risks
University of South Florida-led research identifies individual hosts more or less likely to escalate outbreaks.

Researchers study bacterial immunity to understand infectious disease
Patients with cystic fibrosis are often infected by pseudomonas aeruginosa, a bacterium that infects the lungs and prevents breathing, often causing death.

National Academies target opioid abuse and infectious disease consequences
The National Academies of Sciences, Engineering, and Medicine today released proceedings of a March 12 workshop exploring the rise in infectious diseases accompanying opioid abuse, and possible strategies for reducing both epidemics.

Read More: Infectious Disease News and Infectious Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.